> top > docs > PubMed:16609016 > annotations

PubMed:16609016 JSONTXT

Annnotations TAB JSON ListView MergeView

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 708-724 HP_0012125 denotes prostate cancers
T2 717-724 HP_0002664 denotes cancers
T3 797-825 HP_0008711 denotes benign prostatic hyperplasia
T4 1497-1512 HP_0012125 denotes prostate cancer
T5 1506-1512 HP_0002664 denotes cancer
T6 1583-1598 HP_0012125 denotes prostate cancer
T7 1592-1598 HP_0002664 denotes cancer

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
16609016-0#0#21#gene6143 265-669 gene6143 denotes RPL19) to be overexpressed in the malignant cells. Northern blot hybridization analysis done on a wide range of human cell lines and tissues confirmed the level of RPL19 mRNA to be 5-fold higher in malignant cell lines and 8-fold higher in malignant tissues, when compared with their benign counterparts. Analysis of RPL19 mRNA expression by in situ hybridization revealed a significant increase of RPL19
16609016-0#55#70#diseaseC0376358 1399-1512 diseaseC0376358 denotes predictive of shorter patient survival (P < 0.05), revealing RPL19 to be a sensitive predictor of prostate cancer
16609016-0#55#70#diseaseC0600139 1399-1512 diseaseC0600139 denotes predictive of shorter patient survival (P < 0.05), revealing RPL19 to be a sensitive predictor of prostate cancer
0#21#gene614355#70#diseaseC0376358 16609016-0#0#21#gene6143 16609016-0#55#70#diseaseC0376358 associated_with "RPL19) to be overexpressed in the malignant cells. Northern blot hybridization analysis done on a wide range of human cell lines and tissues confirmed the level of RPL19 mRNA to be 5-fold higher in malignant cell lines and 8-fold higher in malignant tissues, when compared with their benign counterparts. Analysis of RPL19 mRNA expression by in situ hybridization revealed a significant increase of RPL19","predictive of shorter patient survival (P < 0.05), revealing RPL19 to be a sensitive predictor of prostate cancer"
0#21#gene614355#70#diseaseC0600139 16609016-0#0#21#gene6143 16609016-0#55#70#diseaseC0600139 associated_with "RPL19) to be overexpressed in the malignant cells. Northern blot hybridization analysis done on a wide range of human cell lines and tissues confirmed the level of RPL19 mRNA to be 5-fold higher in malignant cell lines and 8-fold higher in malignant tissues, when compared with their benign counterparts. Analysis of RPL19 mRNA expression by in situ hybridization revealed a significant increase of RPL19","predictive of shorter patient survival (P < 0.05), revealing RPL19 to be a sensitive predictor of prostate cancer"

CoMAGC

Id Subject Object Predicate Lexical cue
T1 1369-1374 Gene denotes RPL19
E1 1375-1385 Gene_expression denotes expression
E2 1359-1368 Positive_regulation denotes increased
T2 1497-1512 prostate cancer denotes prostate cancer
R1 T1 E1 themeOf RPL19,expression
R2 E1 E2 themeOf expression,increased
R3 T1 T2 CGE-increased RPL19,prostate cancer
R4 T1 T2 CCS-unidentifiable RPL19,prostate cancer
R5 T1 T2 PT- RPL19,prostate cancer
R3 T1 T2 IGE- RPL19,prostate cancer

DisGeNET

Id Subject Object Predicate Lexical cue
T0 1272-1277 gene:6143 denotes RPL19
T1 1245-1255 disease:C0007097 denotes carcinomas
R1 T0 T1 associated_with RPL19,carcinomas